GenesyzeNews

News

Scroll down to discover more…

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

The network will deliver a programme of projects to accelerate innovation, standardise practice and promote research to identify more cost effective and personalised approaches to the prevention and management of cGvHD.  The programme will be delivered by clinical experts, academics and scientists across 17 European countries by 2022.

Read more about the Integrated EU Network
Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out.  #theTOMs supporting Kidscan charity

Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out. #theTOMs supporting Kidscan charity

CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out.  #theTOMs supporting Kidscan charity

Read
Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Read
CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

Read
Genesyze sponsor conference session at 4th Annual Pharmacon Asia 2017,  19-22 September, One Farrer Hotel & Spa, Singapore

Genesyze sponsor conference session at 4th Annual Pharmacon Asia 2017, 19-22 September, One Farrer Hotel & Spa, Singapore

Read
Nanoparticles are changing the face of biomedical research

Nanoparticles are changing the face of biomedical research

Read
Economist Report: A chance finding may lead to a treatment for multiple sclerosis

Economist Report: A chance finding may lead to a treatment for multiple sclerosis

Read
Colette Hamilton is an approved speaker on leveraging real world evidence at the Pharma Market Access and Pricing Summit Asia in Singapore 20/21 September 2017

Colette Hamilton is an approved speaker on leveraging real world evidence at the Pharma Market Access and Pricing Summit Asia in Singapore 20/21 September 2017

Read
Study reveals treatment gap in patients suffering from an irregular heartbeat

Study reveals treatment gap in patients suffering from an irregular heartbeat

SCIENMAG (2017) Study-reveals-treatment-gap-in-patients-suffering-from-an-irregular-heartbeat/ Accessed here (link), on 13.06.2017

Read
New EU office base for Genesyze

New EU office base for Genesyze

Read
Dr. Ravi Jandhyala, Chief Medical Officer of Genesyze, presents the results of new research on rare disease registries

Dr. Ravi Jandhyala, Chief Medical Officer of Genesyze, presents the results of new research on rare disease registries

Jandhyala, R. (2017), Rare disease registries: What have we learned from them?, Evidence Europe 2017, London Accessed here (link), on 23.02.2017

Read
Researchers in Denmark analyse big data and find more than 30,000 candidates for drug repurposing

Researchers in Denmark analyse big data and find more than 30,000 candidates for drug repurposing

University of Southern Denmark. (2016, November 29). Using drugs for different diseases than initially intended for. ScienceDaily. Retrieved from Accessed here (link), on 7.12.2016

Read
Genesyze will be presenting at Evidence Europe Congress 2017, 22-23 February, Victoria Park Plaza London

Genesyze will be presenting at Evidence Europe Congress 2017, 22-23 February, Victoria Park Plaza London

Read
Rare leukaemia that left doctors confounded was diagnosed by artificial intelligence in Japan

Rare leukaemia that left doctors confounded was diagnosed by artificial intelligence in Japan

Read
UK Government announces extra £2bn investment in research

UK Government announces extra £2bn investment in research

Read
21 cancer centres in China adopt a cognitive computing system to assist physicians to optimise treatment.

21 cancer centres in China adopt a cognitive computing system to assist physicians to optimise treatment.

The system analyses big data to propose evidence based answers to complex problems.

Read
Payors accept surrogate end points for survival after finding that clinical trial results are not born out by real world data

Payors accept surrogate end points for survival after finding that clinical trial results are not born out by real world data

Read

REACH OUT TODAY

Arrange a call back...

Please leave this field empty.
curve
curve

Latest News

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Read more about the Integrated EU Network
Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out.  #theTOMs supporting Kidscan charity

Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out. #theTOMs supporting Kidscan charity

Read
Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Read
CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

Read

This website uses cookies to give you the best experience. If you continue to use this site, we’ll assume that you’re happy to receive all cookies. View our Cookie Policy here.